Using a surrogate with heterogeneous utility to test for a treatment effect
From MaRDI portal
Publication:6629910
DOI10.1002/SIM.9602zbMATH Open1547.62399MaRDI QIDQ6629910
Tianxi Cai, Lu Tian, Layla Parast
Publication date: 30 October 2024
Published in: Statistics in Medicine (Search for Journal in Brave)
Cites Work
- Title not available (Why is that?)
- The evaluation of surrogate endpoints.
- Surrogate measures and consistent surrogates
- A Measure of the Proportion of Treatment Effect Explained by a Surrogate Marker
- Analysis of randomized comparative clinical trial data for personalized treatment selections
- Evaluating Candidate Principal Surrogate Endpoints
- Inference using surrogate outcome data and a validation sample
- Using a surrogate marker for early testing of a treatment effect
- Effectively Selecting a Target Population for a Future Comparative Study
Related Items (1)
This page was built for publication: Using a surrogate with heterogeneous utility to test for a treatment effect
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6629910)